MODIFIED PROTAMINE WITH REDUCED IMMUNOGENICITY

摘要

The present invention relates to polypeptides to be administered especially to humans and in particular for therapeutic use. The polypeptides are modified polypeptides whereby the modification results in a reduced propensity for th e polypeptide to elicit an immune response upon administration to the human subject. The invention in particular relates to the modification of protamin e to result in protamine proteins that are substantially non-immunogenic or le ss immunogenic than any non-modified counterpart when used in vivo.